Showing results (421-430 of 472) with videos related to

Sort By:
Pageof 48
European Urology Oncology|December 14, 2023
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic TherapiesGhady Bou-Nehme Sawaya, Alice Dragomir, Lori A Wood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 27, 2023
High-dose chemotherapy with autologous stem-cell transplantation for relapsed metastatic germ cell tumors The Alberta experienceHanbo Zhang, Nimira S Alimohamed, Naveen S Basappa, et al.
Cancers|February 13, 2025
Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status PatientsNoa Shani Shrem, Ana-Alicia Beltran-Bless, Sunita Ghosh, et al.
ESMO Open|June 20, 2024
Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumK Takemura, T Yuasa, A Lemelin, et al.
Clinical Genitourinary Cancer|April 27, 2025
Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World StudyGhady Bou-Nehme Sawaya, Simon Tanguay, Lori A Wood, et al.
BJUI Compass|August 11, 2022
Patterns of care for non-metastatic castration-resistant prostate cancer: A population-based studyShawn Malone, Christopher J D Wallis, Richard Lee-Ying, et al.
Clinical Genitourinary Cancer|March 6, 2026
Node Positive Resected Renal Cell Carcinoma Portends a Poor Prognosis: Results From the Canadian Kidney Cancer CollaborationJesse Tr Spooner, Christopher Bitcon, Wyatt MacNevin, et al.
The Journal of Urology|December 27, 2022
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database ConsortiumKosuke Takemura, Vishal Navani, Matthew S Ernst, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 6, 2019
Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective DatabaseI Kushnir, L Kirk, R Mallick, et al.
European Urology|January 27, 2023
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell CarcinomaMatthew S Ernst, Vishal Navani, J Connor Wells, et al.
Pageof 48